Literature DB >> 29696506

Point-of-care hemoglobin A1c testing in postmortem examination.

Joo-Young Na1.   

Abstract

Glycated hemoglobin (HbA1c) is a good marker for monitoring glycemic control, and an elevated postmortem blood HbA1c level might indicate poor glycemic control during the antemortem period. The HbA1c level can be measured as a point-of-care (POC) test. In forensic medicine, POC testing is useful for performing autopsies and postmortem inspections since POC testing is both rapid and efficient. This study evaluated HbA1c levels in the capillary and cardiac venous blood of postmortem specimens as well as the usefulness of evaluating HbA1c levels as POC testing in postmortem examinations. For HbA1c testing performed on 103 autopsy cases, a portable SD A1cCare (test) was used for the POC testing, along with a Cobas Integra 800 (comparative). There was a strong correlation between HbA1c levels from postmortem capillary and cardiac venous blood (regression equation, 0.000 + 1.000×), and between HbA1c levels of cardiac venous blood measured using the portable SD A1cCare as a POC test and the Cobas Integra 800 (regression equation, -0.532 + 1.080×). HbA1c levels measured up to 4 weeks following the autopsy with the SD A1cCare had a tendency to decline. The author concluded that HbA1c POC testing can be used during postmortem inspection and during autopsy to accurately identify patients who had uncontrolled diabetes mellitus.

Entities:  

Keywords:  Autopsy; Diabetes mellitus; Forensic pathology; Glycated hemoglobin A; Point-of-care testing

Mesh:

Substances:

Year:  2018        PMID: 29696506     DOI: 10.1007/s12024-018-9978-6

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  6 in total

Review 1.  Standardization of HbA1c measurements--a consensus statement.

Authors:  S M Marshall; J H Barth
Journal:  Diabet Med       Date:  2000-01       Impact factor: 4.359

Review 2.  Post-mortem biochemistry of vitreous humor and glucose metabolism: an update.

Authors:  Camille Boulagnon; Roselyne Garnotel; Paul Fornes; Philippe Gillery
Journal:  Clin Chem Lab Med       Date:  2011-06-10       Impact factor: 3.694

3.  Performance evaluation of SD A1cCare as a HbA1c analyzer for point-of-care testing.

Authors:  Kyunghoon Lee; Sun-Hee Jun; Minje Han; Sang Hoon Song; Kyoung Un Park; Woon Heung Song; Junghan Song
Journal:  Clin Biochem       Date:  2015-03-25       Impact factor: 3.281

4.  Biochemical blood markers and sampling sites in forensic autopsy.

Authors:  Koichi Uemura; Kaori Shintani-Ishida; Kanju Saka; Makoto Nakajima; Hiroshi Ikegaya; Yousuke Kikuchi; Ken-ichi Yoshida
Journal:  J Forensic Leg Med       Date:  2008-03-10       Impact factor: 1.614

5.  Update on the American Diabetes Association Standards of Medical Care.

Authors:  Bruce S Zitkus
Journal:  Nurse Pract       Date:  2014-08-16

6.  Investigation of markers to indicate and distinguish death due to alcoholic ketoacidosis, diabetic ketoacidosis and hyperosmolar hyperglycemic state using post-mortem samples.

Authors:  Joanna Hockenhull; Waljit Dhillo; Rebecca Andrews; Sue Paterson
Journal:  Forensic Sci Int       Date:  2011-08-12       Impact factor: 2.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.